-
All Resources
(choose a category)
-
All Resources
-
selected
Evidence
Evidence, advice, guidance and standards
-
Improvement
Improvement and implementation support
-
Scrutiny
Assurance, scrutiny, measurement and reporting
-
-
Healthcare Area
- Blood and immune system
- Cancer
- Cardiovascular system
- Caring for older people
- Dermatology
- Digestive system
- Ear, nose and throat
- Endocrine, nutritional and metabolic
- Eye
- Genitourinary system
- Health service organisation and delivery
- Infectious disease
- Injuries, accidents and wounds
- Learning disability
- Mental and behavioural disorders
- Mouth and dental
- Musculoskeletal system
- Nervous system
- Obstetrics and gynaecology
- Paediatrics
- Palliative care
- Patient experience
- Physical disability
- Public health
- Respiratory system
- Resource Type
- Programme
- Year
- Page 1 of 48
- next
478 results found filtered by Evidence Remove Evidence Filter Clear Search
-
Dynamic elastomeric fabric orthoses (DEFOs) for cerebral palsy: Technologies scoping report 14
- Published
- 24 May 2013
- Cycle of Improvement
- Evidence
-
Dynamic elastomeric fabric orthoses (DEFOs) for cerebral palsy: Advice Statement 005-13
- Published
- 24 May 2013
- Cycle of Improvement
- Evidence
-
NICE STA Guidance no 283 - Macular oedema (retinal vein occlusion) - ranibizumab
- Published
- 22 May 2013
- Cycle of Improvement
- Evidence
-
NICE STA Guidance no 284 Bevacizumab in combination with paclitaxel and carboplatin for ovarian cancer
- Published
- 22 May 2013
- Cycle of Improvement
- Evidence
-
NICE STA guidance 286 - Schizophrenia or bipolar disorder - loxapine inhalation (terminated appraisal)
- Published
- 22 May 2013
- Cycle of Improvement
- Evidence
-
NICE STA Guidance no 285 - Bevacizumab in combination with gemcitabine & carboplatin for ovarian cancer
- Published
- 22 May 2013
- Cycle of Improvement
- Evidence
-
Radical prostatectomy for localised prostate cancer: evidence note 49
- Published
- 14 May 2013
- Cycle of Improvement
- Evidence
-
Radical prostatectomy for localised prostate cancer: Advice Statement 004-13
- Published
- 14 May 2013
- Cycle of Improvement
- Evidence
-
NICE MTA guidance no 278 - Omalizumab for treating severe persistent allergic asthma
- Published
- 24 April 2013
- Cycle of Improvement
- Evidence
-
NICE STA guidance no 280 - Rheumatoid arthritis (2nd line) - abatacept (rapid review of TA 234)
- Published
- 24 April 2013
- Cycle of Improvement
- Evidence